Aktie A3DNFK COMERA LIFE SCIENCES HOLDINGS, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Comera Life Sciences Holdings, Inc.

Aktien

A3DNFK

US20037C1080

CMRA

Markt geschlossen - OTC Markets
Andere Börsenplätze
 15:30:01 17.05.2024 		% 5 Tage % 1. Jan.
0,0292 USD -4,72 % Intraday Chart für Comera Life Sciences Holdings, Inc. +38,21 % -46,73 %
30.01. Comera Life Sciences Holdings, Inc. kündigt Wechsel des Chief Executive Officer an CI
30.01. Comera Life Sciences Holdings, Inc. kündigt Änderungen im Vorstand an CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Comera Life Sciences Holdings, Inc. Announces Chief Executive Officer Changes
Comera Life Sciences Holdings, Inc. Announces Changes to Its Board
Comera Life Sciences Announces Bridge Financing and Exercise of Take Private Option
Comera Life Sciences Holdings, Inc. announced that it has received $1.5 million in funding
Comera Life Sciences Announces Process Exploring Strategic Alternatives
Comera Life Sciences Holdings, Inc.(OTCPK:CMRA) dropped from S&P TMI Index
Comera Life Sciences Holdings, Inc.(OTCPK:CMRA) dropped from NASDAQ Composite Index
Comera Life Sciences Appoints Dorothy Clarke to Board of Directors
Comera Life Sciences Appoints Dorothy Clarke to Board of Directors
Comera Life Sciences Holdings, Inc. Appoints Dorothy Clarke to Board of Directors
Comera Life Sciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Earnings Flash (CMRA) COMERA LIFE SCIENCES Posts Q3 Revenue $136,310
Comera Life Sciences Reports Financial Results for Third Quarter 2023 and Recent Business Highlights
Comera Life Sciences Presents SQore™ Platform Technology Data at PODD: Partnerships in Drug Delivery Conference
Comera Life Sciences Holdings, Inc. Announces Resignation of Neal Muni, MD as Executive Vice President and Chief Operating Officer
Comera Life Sciences Announces the Completion of $4.1 Million Private Placement
Comera Life Sciences Holdings, Inc. announced that it has received $4.069993 million in funding
Comera Life Sciences Announces Publication of Study Reinforcing Caffeine’s Viscosity Reducing Capabilities
Comera Life Sciences Holdings, Inc. Announces Publication of Study Reinforcing Caffeine's Viscosity Reducing Capabilities
Comera Life Sciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3DNFK Aktie
  4. Nachrichten Comera Life Sciences Holdings, Inc.
  5. Andere Sprachen